Cite

1. Gratas-Delamarche A, Derbre F, Vincent S, Cillard J. Physical inactivity, insulin resistance, and the oxidative-inflammatory loop. Free Rad Res. 2014;1:93-108. https://doi.org/10.3109/10715762.2013.84752810.3109/10715762.2013.84752824060092Open DOISearch in Google Scholar

2. Nikolaidis MG, Kyparos A, Spanou C, Paschalis V, Theodorou AA, Vrabas IS. Redox biology of exercise: an integrative and comparative consideration of some overlooked issues. J Exp Biol. 2012;215(10):1615-25. https://doi.org10.1242/jeb.06747010.1242/jeb.06747022539728Search in Google Scholar

3. Rauch HG, Schonbachler G, Noakes TD. Neural correlates of motor vigour and motor urgency during exercise. Sports Med. 2013;43:227-241. https://doi.org10.1007/s40279-013-0025-110.1007/s40279-013-0025-1360772123456492Open DOISearch in Google Scholar

4. Wilmor JH, Costill DI. Physiology of sport and exercise. Illinois: Human Kinetics; 2004:726Search in Google Scholar

5. Lukyanchuk VD, Simonova IV. Actoprotectors: pharmacology and pharmacotherapy. Pharmacol Med Toxicol. 2015;2:14-26Search in Google Scholar

6. Oliynyk S, Oh S. The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance. Biomols Ther. 2012;20(5):446-56. https://doi.org10.4062/biomolther.2012.20.5.44610.4062/biomolther.2012.20.5.446376228224009833Open DOISearch in Google Scholar

7. Kolomoets OS, Nosulenko IS, Voskoboynik ОY, Berest GG, Kovalenko SI, Trzhetsinsky SD. Actoprotective activity of 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones. Curr Issues Pharm Med Sci Pract. 2016;3:59-66. https://doi.org10.14739/2409-2932.2016.3.7799610.14739/2409-2932.2016.3.77996Search in Google Scholar

8. Kolomoets OS, Voskoboynik ОY, Nosulenko IS, Kryvoshey OV, Avramenko AI, Berest GG. 3’-R-spiro[cycloalkyl-1(2),(hetaryl-3 (4), 6’-[1,2,4]triazino[2,3-c]quinazoline]-2’(7’H)-2-оnes as a perspective class of compounds with actoprotective activity. Zaporozhye Med J. 2017;19:227-32. https://doi.org/10.14739/2310-1210.2017.2.9574810.14739/2310-1210.2017.2.95748Search in Google Scholar

9. Saienko A, Voloshchuk N, Toziuk O, Kryvoviaz O, Kryvoviaz S, Koval V. Assessment of MT-279 compound effect on physical endurance of rats under conditions of chronic hypokinesia. Current Issues in Pharmacy and Medical Sciences. 2017;3:134-7. https://doi.org/10.1515/cipms-2017-002410.1515/cipms-2017-0024Open DOISearch in Google Scholar

10. Stepanjuk GІ, Toziuk OYu, Kovalenko SІ, Chornoіvan NG, Antipenko LM, Antipenko OM, inventors; National Pirogov Memorial Medical University, Vinnytsya, assignee. 5-R-thiotetrazolo[1,5-c]quinazolines which increase the physical endurance. Ukraine Patent 79229. 2013 Apr 10; Bulleten 7Search in Google Scholar

11. Toziuk O, Kryvoviaz O, Kryvoviaz S, Ivko T, Balicka O. Effect of 5-R-Thio-Tetrazolo[1,5-C]Quinazoline Derivatives on the Physical Performance in Different Types of Physical Exercise. Asian J Pharm. 2017;11(3)(Suppl):532-5. http://dx.doi.org/10.22377/ajp.v11i03.145510.22377/ajp.v11i03.1455Search in Google Scholar

12. Antypenko OM, Kovalenko SI, Karpenko OV. Synthesis and hydrolytic cleavage of tetrazolo[1,5-c]quinazolines. Synth Commun. 2016;46:551-5. http://doi.org/10.1080/00397911.2016.115613110.1080/00397911.2016.1156131Open DOISearch in Google Scholar

13. Toziuk O. Investigation of effect of sodium 2-(tetrazolquinazolin-5-iltio)-acetate (compound KB-28) on the metabolic processes in organism during intensive exercise. ScienceRise: Pharmaceutical Science. 2016;4:60-4. https://doi.org/10.15587/2519-4852.2016.8801010.15587/2519-4852.2016.88010Search in Google Scholar

14. Toziuk O, Voloshchuk N, Germanyuk T, Kryvoviaz O, Kryvoviaz S, Ivko T et. al. Characteristics of 2-(tetrazol[1,5-c]quinazolin-5-ylthio) acetate effect on the level of adenine nucleotides in intense physical activity. International Journal of Green Pharmacy. 2017;4:276-80. http://doi.org/10.22377/ijgp.v10i04.129510.22377/ijgp.v10i04.1295Search in Google Scholar

15. Contarteze RV, Manchado FB, Gobatto CA, De Mello MA. Stress biomarkers in rats submitted to swimming and treadmill running exercises. Comp Biochem Physiol A Mol Integr Physiol. 2008;151(3):415-22. http://doi.org/10.1016/j.cbpa.2007.03.00510.1016/j.cbpa.2007.03.00517428717Open DOISearch in Google Scholar

16. Hubner-Wozniak I, Kosmol A, Blachnio D. Anaerobic capacity of upper and lower limbs muscles in combat sports contestants. J Combat Sports and Martial. 2011;2(2):91-4. http://doi.org/10.5604/20815735.104714010.5604/20815735.1047140Open DOISearch in Google Scholar

17. Chamari K, Padulo J. ‘Aerobic’ and ‘Anaerobic’ terms used in exercise physiology: a critical terminology reflection. Sports Med Open. 2015;1(9):1-4. http://doi.org/10.1186/s40798-015-0012-110.1186/s40798-015-0012-1501608427747843Open DOISearch in Google Scholar

18. Kits Van Heijningen AJ, Kemp A. Free and fixed glycogen in rat muscle. Biochem J. 1955;59:487-9110.1042/bj0590487121627314363124Search in Google Scholar

19. Selye H. 1974. Stress without Distress. Philadelphia: Lippincott.Search in Google Scholar

20. Baker JS, McCormick MC, Robergs RA. Interaction among skeletal muscle metabolic energy systems during intense exercise. J Nutr Metab. 2010;Article ID 905612:2-13. http://dx.doi.org/10.1155/2010/90561210.1155/2010/905612300584421188163Search in Google Scholar

21. Eizadi M, Nazem F, Zarifyan A, Eghdami A, Khorshidi D. The Effect of Chronic Intake of L-carnitine L-tartrate on Lipid Metabolism during Aerobic Exercise. J Kerman U Med Sci. 2010;17(2):113-20Search in Google Scholar

22. Ji LL, Zhang Y. Antioxidant and anti-inflammatory effects of exercise: role of redox signaling. Free Rad Res. 2013;48(1):3-11. http://doi.org/10.3109/10715762.2013.84434110.3109/10715762.2013.84434124083482Open DOISearch in Google Scholar

23. Pingitore A, Lima G, Mastorci F, Quinones A, Iervasi G, Vassalle C. Exercise and oxidative stress: Potential effects of antioxidant dietary strategies in sports. Nutrition. 2015;31(7-8):916-22. http://doi.org/10.1016/j.nut.2015.02.00510.1016/j.nut.2015.02.00526059364Open DOISearch in Google Scholar

eISSN:
2300-6676
ISSN:
2084-980X
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy